Related Experiment Video
Updated: Sep 13, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Exploring the Ethical Landscape of Pediatric Neuroendovascular Treatments
Samyami Sangeeta Chowdhury1, Kayla Wiebe2, Greg James3
1Division of Neurology, Department of Paediatrics (S.S.C., N.D.), The Hospital for Sick Children, University of Toronto, Canada.
Insights
Treating pediatric neurovascular disease presents significant ethical challenges due to high stakes and long-term implications. Addressing informed consent, best interests, and global health is crucial for ethical management.
Area of Science:
- Pediatric Neurology
- Medical Ethics
- Neurovascular Medicine
Background:
- Neurovascular diseases in children carry high risks of severe neurological injury or death.
- Decisions regarding treatment for pediatric neurovascular conditions have profound, lifelong consequences for young patients.
- Long-term neurodisability and its impact on a child's future are critical considerations.
Purpose of the Study:
- To explore and discuss key ethical principles and challenges in pediatric neurovascular disease management.
- To address specific ethical issues including informed consent, best interests, and beneficence vs. nonmaleficence.
- To examine the ethical implications of emerging technologies and global health disparities in pediatric neurovascular care.
Main Methods:
- Literature review and discussion of ethical frameworks.
- Analysis of contemporary clinical management practices in pediatric neurovascular disorders.
- Exploration of ethical considerations related to genotype-directed pharmacotherapy and precision child health.
Main Results:
- Pediatric neurovascular disease management involves complex ethical dilemmas.
- Key ethical challenges include informed consent, defining best interests, and balancing treatment benefits against burdens.
- Evolving technologies and precision medicine introduce new ethical frontiers requiring high ethical literacy.
Conclusions:
- Ethical considerations are paramount in the treatment of pediatric neurovascular diseases.
- A comprehensive understanding of ethical principles is essential for healthcare professionals.
- Future advancements in precision child health necessitate advanced ethical preparedness in neurovascular units.
Abstract:
The treatment of neurovascular disease in children continues to push clinical and innovative boundaries, carrying with them uniquely high stakes. Hemorrhage from, or occlusion of, a major cerebral blood vessel may result in devastating neurological injury or death. In children and young people, the stakes around a decision to offer or withhold treatment are even greater. The implications of long-term neurodisability in a young child who may live for many decades with the aftermath of brain injury must also be considered. Contemporary clinical management of children with neurovascular disorders involves a wide range of unique ethical challenges. Evolving technologies for neurovascular diagnosis and treatment will be accompanied by new and unprecedented ethical issues. In this article, we explore and discuss the key ethical principles, frameworks, and broader challenges pertinent to pediatric neurovascular disease and its management; challenges to informed consent, best interests, balancing beneficence, burden and nonmaleficence, ethics related to genotype-directed pharmacotherapy, and global health considerations are addressed. Precision child health will see an increase in volume of patients, particularly for tertiary/quaternary neurovascular units, where ethical considerations will be pushed into a new frontier, requiring a high level of ethical literacy from all team members.
Related Concept Videos
Ethical Issues
Ethical Concerns in Healthcare:
Aneurysm III: Interprofessional Care
Standards of Care II
Standards of Care I
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Aneurysm IV: Nursing Management

